Boehringer Ingelheim Pty Ltd is a foreign-owned private company that derives its revenue from the importation, exportation, marketing and selling of pharmaceuticals, chemical and animal health products in Australia and New Zealand. The company employs 400 people and is administered from its head office in North Ryde, New South Wales. 

Boehringer Ingelheim Pty Ltd is a wholly owned subsidiary of C H Boehringer Sohn AG & Co KG, a German pharmaceuticals company.

Boehringer Ingelheim is primarily concerned with the importing, exporting and marketing and sale of pharmaceutical, chemical and animal health products.

Business lines include:

  • Prescription Medicines
  • Consumer Health Care
  • Animal Health
  • Duboisia Farms

Some of the brands the company offers include:

  • Prescription Medicines: Actilyse, Aptivus, Glitrif, and Imukin amongst other brands
  • Consumer Health Care: Bisolvon, Buscopan, Dulcofibre and Dulcolax amongst other brands
  • Animal Health products: Vetmedin, Fel-O-Vax and Sputolysin amongst other brands
  • Duboisia: Boehringer Ingelheim manages farms that grow Duboisia from which the company extracts alkaloids; a chemical used to produce Buscopan.

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

Table of Contents

Company Details
Key Personnel
Growth & Ratios
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.